About this document

Switching to Tenofovir Alafenamide in CHB by Anh Nguyen is a document available to read on EtoBox.

This review article discusses the efficacy and safety of switching patients with chronic hepatitis B (CHB) from other nucleos(t)ide analogues (NAs) to tenofovir alafenamide (TAF). The findings indicate that switching to TAF maintains or improves virological and biochemical responses while enhancing renal and bone safety, particularly beneficial for patients at risk of complications. The review supports the recommendation of TAF as a preferred treatment option in specific patient populations based on individ

Author

Anh Nguyen

Language

EN